食管鳞状细胞癌18F-FDG PET/CT肿瘤SUV与侵袭性病理特征的关系
回顾性分析220例未行新辅助治疗、手术切除的临床I-II期食管鳞状细胞癌患者,测量治疗前FDG PET/CT原发肿瘤SUVmax。ROC曲线分析显示预测局部进展期疾病的最佳SUVmax截断值为4.0(AUC=0.844,P<0.001)。较高的肿瘤SUVmax与更深的肿瘤浸润、淋巴结转移阳性、淋巴管瘤栓、神经周围侵犯、较高的Ki-67指数及肿瘤低分化显著相关。
要点
- 临床I-II期食管鳞癌术后病理升级至III-IV期者43例(19.5%)。
- 预测局部进展期疾病的最佳SUVmax截断值为4.0,AUC=0.844,P<0.001。
- 较高SUVmax与更深浸润、淋巴结转移、淋巴管瘤栓、神经周围侵犯、高Ki-67及低分化相关。
核心结论
- 治疗前FDG PET/CT测量的SUVmax与侵袭性病理特征显著相关,可能帮助临床医生识别有进展期疾病风险的患者。
研究设计与样本
- 回顾性分析220例手术切除、未行新辅助治疗的临床I-II期食管鳞状细胞癌患者,测量治疗前FDG PET/CT原发肿瘤SUVmax,病理特征包括肿瘤浸润深度、淋巴结转移、肿瘤分化、淋巴管瘤栓、神经周围侵犯、Ki-67指数和p53蛋白表达,采用ROC曲线分析确定预测病理进展期疾病的最佳SUVmax截断值,采用t检验或χ检验分析SUVmax相关病理特征差异。
主要发现
- 从临床I-II期升级至病理III-IV期的患者数为43例(19.5%)。
- ROC曲线分析显示最佳SUVmax截断值4.0对预测局部进展期疾病性能良好(AUC=0.844,P<0.001)。
- 较高的肿瘤SUVmax与更深的肿瘤浸润(超过黏膜下层,P<0.001)显著相关。
- 较高的肿瘤SUVmax与淋巴结转移阳性(P<0.001)、淋巴管瘤栓存在(P<0.001)、神经周围侵犯存在(P<0.001)显著相关。
- 较高的肿瘤SUVmax与较高的Ki-67指数(P=0.025)及肿瘤低分化(P=0.039)显著相关。
关键数值与推荐
- 预测局部进展期疾病的最佳SUVmax截断值为4.0(AUC=0.844,P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Considerable discrepancies are observed between clinical staging and pathological staging after surgical resection in patients with esophageal squamous cell carcinoma (ESCC). In this study, we examined the relationships between tumor SUVs on FDG PET/CT and aggressive pathological features in resected ESCC patients. METHODS: A total of 220 patients with surgically resected clinical stage I-II ESCC without neoadjuvant treatment were retrospectively analyzed. SUVmax of the primary tumor was measured on pretreatment FDG PET/CT. Pathological features included depth of tumor invasion, lymph node metastasis, tumor differentiation, lymphatic vessel tumor embolus, perineural invasion, Ki-67 index, and p53 protein expression. Receiver operating characteristic curve analysis was used to determine an optimal cutoff of SUVmax to predict pathologically advanced disease. Differences in pathological features associated with SUVmax were examined by t test or χ test. RESULTS: The number of patients upstaged from clinical stage I-II to pathological stage III-IV was 43 (19.5%). Receiver operating characteristic curve analysis showed that the optimal cutoff SUVmax of 4.0 had good performance for predicting locally advanced disease (area under the receiver operating characteristic curve = 0.844, P < 0.001). Higher tumor SUVmax was significantly associated with advanced depth of tumor invasion (deeper than submucosa, P < 0.001), positive lymph node metastasis (P < 0.001), presence of lymphatic vessel tumor embolus (P < 0.001), presence of perineural invasion (P < 0.001), higher Ki-67 index (P = 0.025), and poor tumor differentiation (P = 0.039). CONCLUSIONS: SUVmax measured on pretreatment FDG PET/CT is significantly associated with aggressive pathological features and may help clinicians identify patients at risk of advanced disease.
引用
- Lim CH, Park YJ, Shin M, et al. Tumor SUVs on 18F-FDG PET/CT and Aggressive Pathological Features in Esophageal Squamous Cell Carcinoma. Clin Nucl Med. 2020. PMID: 31977480. doi:10.1097/RLU.0000000000002926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。